Predictive analytics for intelligent biopharma production

Cytomos is at the forefront of biotechnology innovation, offering a unique technology that focuses on real-time intrinsic single-cell properties to revolutionize both development and manufacturing processes. Their flagship product, AuraCyt™, utilizes dielectric spectroscopy combined with consumer microelectronics to provide fast and sensitive label-free detection of single-cell attributes. This technology addresses significant analytical challenges in the biotech field by enabling real-time monitoring of cell manufacturing events, which helps in saving and optimizing production batches. The system is designed to streamline cell line development by reliably identifying lead clones and predicting high-producing cell lines, while also allowing for the early detection of changes in cell phenotype.

The capabilities of AuraCyt™ position Cytomos as a preferred partner for Process Analytical Technology (PAT) in the realm of single-cell analytics. By offering smarter, less labor-intensive, and more automated processes, Cytomos enhances the efficiency of biotechnological workflows. The multidimensional data generated by their technology not only aids in the optimization of cell manufacturing but also contributes to a deeper understanding of cellular physiology, ultimately driving advancements in biopharmaceutical development and production.

United Kingdom

Providing predictive analytics from suspended-cells through our unbiased cytometry technology, AuraCyt™

Middle Wing Building, University of Edinburgh, Easter Bush Campus, Bush Farm Road, Roslin, Scotland EH25 9RG, GB

Cytomos

Company Details